메뉴 건너뛰기




Volumn 21, Issue 11, 1998, Pages 1101-1107

Long-term follow-up after high-dose therapy for high-risk multiple myeloma

Author keywords

Autotransplant; Long term survival; Myeloma

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN;

EID: 0031803968     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701182     Document Type: Article
Times cited : (47)

References (24)
  • 1
    • 2642657129 scopus 로고    scopus 로고
    • Advances in treatment of multiple myeloma
    • Schrier R (ed). Mosby-Year Book Ine: Illinois
    • Barlogie B, Jagannath S, Tricot G. Advances in treatment of multiple myeloma. In: Schrier R (ed). Advances in Treatment of Multiple Myeloma. Mosby-Year Book Ine: Illinois, 1996, pp 444-448.
    • (1996) Advances in Treatment of Multiple Myeloma , pp. 444-448
    • Barlogie, B.1    Jagannath, S.2    Tricot, G.3
  • 2
    • 0026099489 scopus 로고
    • VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients
    • Boccadoro M, Marmont F, Tribalto M et al VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients. J Clin Oncol 1991; 9: 444-448.
    • (1991) J Clin Oncol , vol.9 , pp. 444-448
    • Boccadoro, M.1    Marmont, F.2    Tribalto, M.3
  • 3
    • 0020578180 scopus 로고
    • High-dose intravenous melphalan for plasma-cell leukemia and myeloma
    • McElwain TJ, Powles R. High-dose intravenous melphalan for plasma-cell leukemia and myeloma. Lancet 1983; 2: 822-824.
    • (1983) Lancet , vol.2 , pp. 822-824
    • McElwain, T.J.1    Powles, R.2
  • 4
    • 0024255829 scopus 로고
    • Prognostic factors with high-dose melphalan for refractory multiple myeloma
    • Barlogie B, Alexanian R, Smallwood L et al. Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 1988; 72: 2015-2019.
    • (1988) Blood , vol.72 , pp. 2015-2019
    • Barlogie, B.1    Alexanian, R.2    Smallwood, L.3
  • 5
    • 0025148754 scopus 로고
    • High-dose melphalan and GM-CSF for refractory multiple myeloma
    • Barlogie B, Jagannath S, Dixon D et al. High-dose melphalan and GM-CSF for refractory multiple myeloma. Blood 1990; 76: 677-680.
    • (1990) Blood , vol.76 , pp. 677-680
    • Barlogie, B.1    Jagannath, S.2    Dixon, D.3
  • 6
    • 0022510876 scopus 로고
    • High-dose melphalan with autologous bone marrow transplantation for multiple myeloma
    • Barlogie B, Hall R, Zander A et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
    • (1986) Blood , vol.67 , pp. 1298-1301
    • Barlogie, B.1    Hall, R.2    Zander, A.3
  • 7
    • 0023552805 scopus 로고
    • High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
    • Barlogie B, Alexanian R. Dicke K et al. High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987; 70: 869-872.
    • (1987) Blood , vol.70 , pp. 869-872
    • Barlogie, B.1    Alexanian, R.2    Dicke, K.3
  • 8
    • 0025203141 scopus 로고
    • Autologous bone mar- Row transplantation in multiple myeloma: Identification of prognostic factors
    • Jagannath S, Barlogie B, Dicke K et al. Autologous bone mar- row transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
    • (1990) Blood , vol.76 , pp. 1860-1866
    • Jagannath, S.1    Barlogie, B.2    Dicke, K.3
  • 9
    • 0028344647 scopus 로고
    • High-dose melphalan for multiple myeloma: Long-term follow-up data
    • Cunningham D, Paz-Ares ME. Gore ME et al. High-dose melphalan for multiple myeloma: long-term follow-up data. J Clin Oncol 1994; 12: 764-768.
    • (1994) J Clin Oncol , vol.12 , pp. 764-768
    • Cunningham, D.1    Paz-Ares, M.E.2    Gore, M.E.3
  • 10
    • 0028194968 scopus 로고
    • High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
    • Cunningham D. Paz-Ares L, Milan S et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12. 759-763.
    • (1994) J Clin Oncol , vol.12 , pp. 759-763
    • Cunningham, D.1    Paz-Ares, L.2    Milan, S.3
  • 11
    • 0027496486 scopus 로고
    • Monoclonal anti-body-purged bone marrow transplantation therapy for multiple myeloma
    • Anderson KC, Andersen J, Soiffer R et al. Monoclonal anti-body-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-2576.
    • (1993) Blood , vol.82 , pp. 2568-2576
    • Anderson, K.C.1    Andersen, J.2    Soiffer, R.3
  • 12
    • 9244263575 scopus 로고    scopus 로고
    • High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
    • Bensinger WI, Rowley SD, Demirer T et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J Clin Oncol 1996; 14: 1447-1456.
    • (1996) J Clin Oncol , vol.14 , pp. 1447-1456
    • Bensinger, W.I.1    Rowley, S.D.2    Demirer, T.3
  • 13
    • 0029166629 scopus 로고
    • Autologous stem cell transplantation in multiple myeloma: Results of the European group for bone marrow transplantation
    • Bjorkstrand B, Ljungman P, Bird JM et al. Autologous stem cell transplantation in multiple myeloma: results of the European group for bone marrow transplantation. Stem Cells 1995; 13 (Suppl. 2): 140-146.
    • (1995) Stem Cells , vol.13 , Issue.SUPPL. 2 , pp. 140-146
    • Bjorkstrand, B.1    Ljungman, P.2    Bird, J.M.3
  • 14
    • 0029035095 scopus 로고
    • Autologous stem cell transplantation after first remission induction treatment in multiple myeloma; a report of the French registry on autologous transplantation in multiple myeloma
    • Harousseau J, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma; a report of the French registry on autologous transplantation in multiple myeloma. Blood 1995; 85: 3077-3085.
    • (1995) Blood , vol.85 , pp. 3077-3085
    • Harousseau, J.1    Attal, M.2    Divine, M.3
  • 16
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma
    • Durie BGM, Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-854.
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.M.1    Salmon, S.E.2
  • 17
    • 0020656085 scopus 로고
    • Long-term survival in multiple myeloma
    • Kyle RA. Long-term survival in multiple myeloma. New Engl J Med 1983; 308: 314-316.
    • (1983) New Engl J Med , vol.308 , pp. 314-316
    • Kyle, R.A.1
  • 18
    • 0022357528 scopus 로고
    • Ten year survival in multiple myeloma
    • Alexanian R. Ten year survival in multiple myeloma. Arch Intern Med 1985; 145: 2073-2074.
    • (1985) Arch Intern Med , vol.145 , pp. 2073-2074
    • Alexanian, R.1
  • 19
    • 0026733455 scopus 로고
    • Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
    • Jagannath S, Vesole DH, Glenn L et al. Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
    • (1992) Blood , vol.80 , pp. 1666-1672
    • Jagannath, S.1    Vesole, D.H.2    Glenn, L.3
  • 20
    • 0028335814 scopus 로고
    • High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants
    • Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-956.
    • (1994) Blood , vol.84 , pp. 950-956
    • Vesole, D.H.1    Barlogie, B.2    Jagannath, S.3
  • 21
    • 0344813041 scopus 로고    scopus 로고
    • Autotransplants in multiple myeloma: What have we learned?
    • Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
    • (1996) Blood , vol.88 , pp. 838-847
    • Vesole, D.H.1    Tricot, G.2    Jagannath, S.3
  • 22
    • 8944220233 scopus 로고    scopus 로고
    • A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
    • Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
    • (1996) New Engl J Med , vol.335 , pp. 91-97
    • Attal, M.1    Harousseau, J.L.2    Stoppa, A.M.3
  • 23
    • 0031001279 scopus 로고    scopus 로고
    • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
    • Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
    • (1997) Blood , vol.89 , pp. 789-793
    • Barlogie, B.1    Jagannath, S.2    Vesole, D.H.3
  • 24
    • 0345503577 scopus 로고    scopus 로고
    • Total therapy (TT) with tandem autotransplants (2 TX) for 231 newly diagnosed patients (PTS) with multiple myeloma (MM)
    • Abstr. 685a
    • Jagannath S, Tricot G, Vesole D et al. Total therapy (TT) with tandem autotransplants (2 TX) for 231 newly diagnosed patients (PTS) with multiple myeloma (MM). Blood 1996; 88: 10 (Abstr. 685a).
    • (1996) Blood , vol.88 , pp. 10
    • Jagannath, S.1    Tricot, G.2    Vesole, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.